ArticleCirculation2015
Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk, and Predictors.
Article in Circulation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
71 citing papers in PubMed, 3 syntheses or guidelines pooled it, 169 citations in OpenAlex.
- Risk of stroke in patients with congenital heart disease: a systematic review and meta-analysis.BMC neurology · 2024Pooled it
- Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update.Stroke and vascular neurology · 2023Guideline
- Brain vascular changes in adults with congenital heart disease: A systematic review.NeuroImage. Clinical · 2019Pooled it
- Delayed Diagnosis of Congenital Heart Diseases in Adults: Opportunities for Improving Diagnostic Strategies.Journal of cardiovascular development and disease · 2026Review
- Reported Impacts of Congenital Heart Disease on Functional Outcomes in Adults with Down Syndrome.Pediatric cardiology · 2026Article
- Hyperviscosity-Related Ischemic Stroke in an Adolescent With Unrepaired Tetralogy of Fallot: A Case Report From a Resource-Limited Setting.Clinical case reports · 2026Article
- Cardiorenal Biomarkers and Cerebrovascular Risk in Patients with Congenital Heart Disease.Journal of clinical medicine · 2026Article
- Point of care INR monitoring in cyanotic congenital heart disease-related compensatory erythrocytosis.International journal of cardiology. Congenital heart disease · 2026Article
- AI-enhanced flexible ECG patch for accurate heart disease diagnosis, optimal wear positioning, and interactive medical consultation.National science review · 2025Article
- Clinical Characteristics in Adult Congenital Heart Disease Patients With Acute Stroke - A Retrospective Analysis.Circulation reports · 2025Article
- Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures.Nature reviews. Cardiology · 2025Review
- Thromboprophylaxis and adult congenital heart disease: The latest on indications, risk scoring and therapy.International journal of cardiology. Congenital heart disease · 2025Article
- A new strategy for monitoring of direct oral anticoagulants in patients with cyanotic and complex congenital heart disease.International journal of cardiology. Congenital heart disease · 2024Article
- High-Dimensional Single-Cell Mass Cytometry Demonstrates Differential Platelet Functional Phenotypes in Infants With Congenital Heart Disease.Arteriosclerosis, thrombosis, and vascular biology · 2024Article
- Atherosclerotic Risk Factor Prevalence in Adults With Congenital Heart Disease: A Meta-Analysis.JACC. Advances · 2024Article
- Ischemic Stroke in Adults With Congenital Heart Disease: Cumulative Incidence and Associated Factors.Journal of the American Heart Association · 2024Article
- Incidence and Predictors of Stroke in Australian Adults With Congenital Heart Disease (2000-2017).Journal of the American Heart Association · 2024Article
- Ischemic Stroke in Patients With Congenital Heart Disease and Atrial Fibrillation.Journal of the American Heart Association · 2024Article
- Reducing Rates and Risk of Stroke in Adults With Congenital Heart Disease: What Can We Do Now, and What Should We Do Next?Journal of the American Heart Association · 2024Article
- Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial.JACC. Advances · 2024Article
11 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
backgroundStroke is an important cause of morbidity and mortality, although there is a lack of comprehensive data on its incidence, cumulative risk, and predictors in patients with adult congenital heart disease. METHODS AND
resultsThis retrospective study of 29 638 Quebec patients with adult congenital heart disease aged 18 to 64 years between 1998 and 2010 was based on province-wide administrative data. The cumulative risk of ischemic stroke estimated up to age 64 years was 6.1% (95% confidence interval [CI], 5.0-7.0%) in women and 7.7% (95% CI, 6.4-8.8%) in men; the risk of hemorrhagic stroke was 0.8% (95% CI, 0.4-1.2%) and 1.3% (95% CI, 0.8-1.8%), respectively. Compared with rates reported for the general Quebec population, age-sex standardized incidence rates of ischemic stroke were 9 to 12 times higher below age 55 years and 2 to 4 times higher in the age group 55 to 64 years; hemorrhagic stroke rates were 5 to 6 times (age <55 years) and 2 to 3 times higher. Using a combination of stepwise model selection and Bayesian model averaging, the strongest predictors of ischemic stroke were heart failure (odds ratio for age group 18-49 years, 5.94 [95% CI, 3.49-10.14], odds ratio for age group 50-64 years, 1.68 [95% CI, 1.06-2.66]), diabetes mellitus (odds ratio, 2.33 [95% CI, 1.66-3.28]), and recent myocardial infarction (odds ratio, 8.38 [95% CI, 1.77-39.58]).
conclusionsAmong patients with adult congenital heart disease, 1 in 11 men and 1 in 15 women experienced a stroke between ages 18 and 64 years. Stroke incidence was considerably higher than in the general population, especially at a younger age. The most important predictors of ischemic stroke were heart failure, diabetes mellitus, and recent myocardial infarction. Additional research is required to see whether advances in the management of adult congenital heart disease may reduce this substantial stroke rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.